Complete FDA and NHTSA recall records dated in April 2025.
These records include useful source details for the selected month.
Chrysler (FCA US, LLC) is recalling certain 2025 Ram 1500 vehicles. A software error may cause an incorrect tire inflation pressure message to display on the instrument panel.
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
Lack of Assurance of Sterility
Failed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed.
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Lack of Assurance of Sterility
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Lack of Assurance of Sterility
Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol
Lack of Assurance of Sterility
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
